MedTrace Logo

Performance and Acceptability of iDesign

NCT01220466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2013-05-20

Study results available
· View outcomes & findings →

Summary

The results of this trial will demonstrate that the iDesign System performs as intended and is acceptable in a clinical setting.

Conditions

  • Refractive Error

Interventions

DEVICE

STAR S4IR LASIK with iDesign Aberrometer

CustomVue LASIK targeted for emmetropia

Sponsors & Collaborators

  • Abbott Medical Optics

    lead INDUSTRY

Principal Investigators

  • Nicholas Tarantino, OD · Abbott Medical Optics

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-06-30
Completion
2011-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01220466 on ClinicalTrials.gov